Essex Woodlands Management, Inc. - Q3 2014 holdings

$275 Million is the total value of Essex Woodlands Management, Inc.'s 10 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 9.1% .

 Value Shares↓ Weighting
RVNC  REVANCE THERAPEUTICS INC$88,764,000
-43.1%
4,592,0470.0%32.32%
-0.5%
ABMD  ABIOMED INC$78,214,000
-1.2%
3,150,0000.0%28.48%
+72.9%
CORI  CORIUM INTL INC$57,429,000
-21.0%
9,353,3040.0%20.91%
+38.3%
ELGX SellENDOLOGIX INC$31,644,000
-47.3%
2,514,936
-10.7%
11.52%
-7.8%
ACUR  ACURA PHARMACEUTICALS INC$7,629,000
-28.4%
10,284,8860.0%2.78%
+25.3%
ZIOP  ZIOPHARM ONCOLOGY INC$7,130,000
-30.5%
2,764,9080.0%2.60%
+21.7%
MNOV  MEDICINOVA INC$3,499,000
+47.3%
1,170,3700.0%1.27%
+157.9%
CRIS  CURIS INC$330,000
-24.1%
233,7970.0%0.12%
+33.3%
PTN  PALATIN TECHNOLOGIES INC$23,000
-4.2%
23,9280.0%0.01%
+60.0%
ECTE  ECHO THERAPEUTICS INC$10,000
-64.3%
12,3190.0%0.00%
-33.3%
HZNP ExitHORIZON PHARMA INC$0-5,815,940
-100.0%
-18.51%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MEDICINOVA INC42Q3 20236.5%
REVANCE THERAPEUTICS INC39Q3 202344.6%
AXOGEN INC26Q4 202143.3%
ENDOLOGIX INC24Q1 201922.5%
ABIOMED INC20Q1 201852.1%
CORIUM INTL INC20Q1 201923.5%
TELA BIO, INC.16Q3 202331.5%
VENUS CONCEPT, INC.16Q3 202321.3%
ACURA PHARMACEUTICALS INC15Q1 20191.4%
CATALYST BIOSCIENCES INC15Q1 20191.0%

View Essex Woodlands Management, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View Essex Woodlands Management, Inc.'s complete filings history.

Compare quarters

Export Essex Woodlands Management, Inc.'s holdings